Post-approval studies (Phase 4)Study completedNCT04168203
What this trial is testing
Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism
Who this might be right for
Deep Vein ThrombosisPulmonary EmbolismVenous Thromboembolism
Brigham and Women's Hospital 600